Healthy Male Clinical Trial
Official title:
A Randomized, Double-blind, Single-dose, Parallel Controlled Phase I Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of Envafolimab in Healthy Male Subjects Before and After the Manufacturing Process Change
The purpose of this study is to evaluate the pharmacokinetic similarity, safety, and immunogenicity of Envafolimab in healthy male subjects before and after the manufacturing process change.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04135898 -
A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects
|
Phase 1 | |
| Completed |
NCT02395926 -
To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers
|
Phase 1 | |
| Active, not recruiting |
NCT06105255 -
A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553
|
Phase 1 | |
| Completed |
NCT01651234 -
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT01359618 -
Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart
|
Phase 1 | |
| Completed |
NCT02395913 -
Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg)
|
Phase 1 | |
| Completed |
NCT06194500 -
A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants
|
Phase 1 | |
| Completed |
NCT05202912 -
Food Effect Study of IDX-1197 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04828265 -
Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects
|
Phase 1 |